Literature DB >> 23247659

Regular recreational physical activity and risk of hematologic malignancies: results from the prospective VITamins And lifestyle (VITAL) study.

R B Walter1, S A Buckley, E White.   

Abstract

BACKGROUND: Conflicting evidence exists on the relationship between physical activity (PA) and incident hematologic malignancies. Herein, we used a large cohort study to examine this association. PATIENTS AND METHODS: Sixty-five thousand three hundred twenty-two volunteers aged 50-76 years were recruited from 2000 to 2002. Incident hematologic malignancies (n = 666) were identified through 2009 by linkage to the Surveillance, Epidemiology, and End Results cancer registry. Hazard ratios (HRs) for hematologic malignancies associated with PA averaged over 10 years before baseline were estimated with Cox proportional hazards models, adjusting for factors associated with hematologic cancers or PA.
RESULTS: There was a decreased risk of hematologic malignancies associated with PA (HR = 0.66 [95% confidence interval, 95% CI 0.51-0.86] for the highest tertile of all PA, P-trend = 0.005, and HR = 0.60 [95% CI 0.44-0.82] for the highest tertile of moderate/high-intensity PA, P-trend = 0.002). These associations were strongest for myeloid neoplasms (HR = 0.48 [95% CI 0.29-0.79] for the highest tertile of all PA, P-trend = 0.013, and HR = 0.40 [95% CI 0.21-0.77] for the highest tertile of moderate/high-intensity PA, P-trend = 0.016). There were also significant associations between PA and chronic lymphocytic leukemia/small lymphocytic lymphoma or other mature B-cell lymphomas except plasma cell disorders.
CONCLUSIONS: Our study offers the strongest epidemiological evidence, to date, to suggest an association between regular PA and dose-dependent risk reduction for most hematologic malignancies, particularly myeloid neoplasms.

Entities:  

Mesh:

Year:  2012        PMID: 23247659      PMCID: PMC3629898          DOI: 10.1093/annonc/mds631

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  45 in total

1.  Delays in cancer diagnosis in underinsured young adults and older adolescents.

Authors:  Sean Martin; Corinne Ulrich; Mark Munsell; Sarah Taylor; Georgia Lange; Archie Bleyer
Journal:  Oncologist       Date:  2007-07

2.  Body size, physical activity, and risk of Hodgkin's lymphoma in women.

Authors:  Theresa H M Keegan; Sally L Glaser; Christina A Clarke; Ronald F Dorfman; Risa B Mann; Joseph A DiGiuseppe; Ellen T Chang; Richard F Ambinder
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-06       Impact factor: 4.254

3.  Risk factors for multiple myeloma: evidence from the Japan Collaborative Cohort (JACC) study.

Authors:  M M H Khan; Mitsuru Mori; Fumio Sakauchi; Keitaro Matsuo; Kotaro Ozasa; Akiko Tamakoshi
Journal:  Asian Pac J Cancer Prev       Date:  2006 Oct-Dec

4.  Physical activity and incidence of cancer in diverse populations: a preliminary report.

Authors:  R S Paffenbarger; R T Hyde; A L Wing
Journal:  Am J Clin Nutr       Date:  1987-01       Impact factor: 7.045

5.  Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma.

Authors:  James R Cerhan; Leslie Bernstein; Richard K Severson; Scott Davis; Joanne S Colt; Aaron Blair; Patricia Hartge
Journal:  Cancer Causes Control       Date:  2005-12       Impact factor: 2.506

6.  Acute exercise stimulates macrophage function: possible role of NF-kappaB pathways.

Authors:  Elza M S Silveira; Mariana F Rodrigues; Maurício S Krause; Damiana R Vianna; Bibiana S Almeida; Juliane S Rossato; Lino P Oliveira; Rui Curi; Paulo I Homem de Bittencourt
Journal:  Cell Biochem Funct       Date:  2007 Jan-Feb       Impact factor: 3.685

Review 7.  Obesity, diet and risk of non-Hodgkin lymphoma.

Authors:  Christine F Skibola
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-03-02       Impact factor: 4.254

8.  Body mass index, physical activity, and risk of multiple myeloma.

Authors:  Brenda M Birmann; Edward Giovannucci; Bernard Rosner; Kenneth C Anderson; Graham A Colditz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-07       Impact factor: 4.254

9.  Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention.

Authors:  Dean Ornish; Mark Jesus M Magbanua; Gerdi Weidner; Vivian Weinberg; Colleen Kemp; Christopher Green; Michael D Mattie; Ruth Marlin; Jeff Simko; Katsuto Shinohara; Christopher M Haqq; Peter R Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-16       Impact factor: 11.205

Review 10.  Physical activity and cancer prevention : pathways and targets for intervention.

Authors:  Connie J Rogers; Lisa H Colbert; John W Greiner; Susan N Perkins; Stephen D Hursting
Journal:  Sports Med       Date:  2008       Impact factor: 11.928

View more
  4 in total

1.  Physical Activity in Cancer Prevention and Survival: A Systematic Review.

Authors:  Anne McTiernan; Christine M Friedenreich; Peter T Katzmarzyk; Kenneth E Powell; Richard Macko; David Buchner; Linda S Pescatello; Bonny Bloodgood; Bethany Tennant; Alison Vaux-Bjerke; Stephanie M George; Richard P Troiano; Katrina L Piercy
Journal:  Med Sci Sports Exerc       Date:  2019-06       Impact factor: 5.411

Review 2.  The skinny on obesity and plasma cell myeloma: a review of the literature.

Authors:  K R Carson; M L Bates; M H Tomasson
Journal:  Bone Marrow Transplant       Date:  2014-05-12       Impact factor: 5.483

3.  An Anecdotal Case Report of Chronic Lymphatic Leukemia with del(11q) Treated with Ibrutinib: Artificial Nourishment and Physical Activity Program.

Authors:  Antonello Sica; Caterina Sagnelli; Alfonso Papa; Massimo Ciccozzi; Evangelista Sagnelli; Armando Calogero; Erika Martinelli; Beniamino Casale
Journal:  Int J Environ Res Public Health       Date:  2020-03-16       Impact factor: 3.390

4.  The relationship between physical activity and lymphoma: a systematic review and meta analysis.

Authors:  Gwynivere A Davies; Christopher Strader; Richa Chibbar; Stefania Papatheodorou; Adam A Dmytriw
Journal:  BMC Cancer       Date:  2020-10-06       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.